Two weeks into the Trump administration, external communication from federal health agencies, including the Centers for Disease Control and Prevention, with the nation and world has gone dark. In the ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

The new junior research group Viral Systems Modeling headed by Dr. Tanja Laske started work at the Leibniz Institute of Virology (LIV) on February 1, 2025. The group is dedicated to computer-assisted ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Most commonly used drugs don’t reduce symptoms, hospitalizations, or mortality rates for low- and high-risk patients.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the promotion of Siobhan Fogarty to chief technical officer. Fogarty, who joined Tonix in 2016, previo ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced that its President and CEO, Seth Lederman, M.D., will present at the BIO CEO & Investor Conference on ...